DE69635010D1 - Verwendung von Mangan-, Yttrium- oder einigen Lanthanidsalzen in einer kosmetischen, dermatologischen oder pharmazeutischen Zusammensetzung insbesondere zur Behandlung empflindlicher Haut - Google Patents
Verwendung von Mangan-, Yttrium- oder einigen Lanthanidsalzen in einer kosmetischen, dermatologischen oder pharmazeutischen Zusammensetzung insbesondere zur Behandlung empflindlicher HautInfo
- Publication number
- DE69635010D1 DE69635010D1 DE69635010T DE69635010T DE69635010D1 DE 69635010 D1 DE69635010 D1 DE 69635010D1 DE 69635010 T DE69635010 T DE 69635010T DE 69635010 T DE69635010 T DE 69635010T DE 69635010 D1 DE69635010 D1 DE 69635010D1
- Authority
- DE
- Germany
- Prior art keywords
- yttrium
- cosmetic
- manganese
- dermatological
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Birds (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9512658A FR2740335B1 (fr) | 1995-10-26 | 1995-10-26 | Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p |
FR9512658 | 1995-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69635010D1 true DE69635010D1 (de) | 2005-09-08 |
DE69635010T2 DE69635010T2 (de) | 2006-04-20 |
Family
ID=9483959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69635010T Expired - Lifetime DE69635010T2 (de) | 1995-10-26 | 1996-10-14 | Verwendung von Mangan-, Yttrium- oder einigen Lanthanidsalzen in einer kosmetischen, dermatologischen oder pharmazeutischen Zusammensetzung insbesondere zur Behandlung empflindlicher Haut |
Country Status (9)
Country | Link |
---|---|
US (1) | US5900257A (de) |
EP (1) | EP0770392B1 (de) |
JP (1) | JP3112844B2 (de) |
AT (1) | ATE300948T1 (de) |
CA (1) | CA2188892C (de) |
DE (1) | DE69635010T2 (de) |
ES (1) | ES2246493T3 (de) |
FR (1) | FR2740335B1 (de) |
NO (1) | NO964517L (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6203803B1 (en) | 1994-12-14 | 2001-03-20 | Societe L'oreal S.A. | Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
DE69601765T2 (de) * | 1995-09-07 | 1999-07-08 | Oreal | Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten |
AT405017B (de) * | 1997-10-06 | 1999-04-26 | Jakoby Marie Luise | Mittel zur stimulation der körpereigenen abwehr |
IL133077A0 (en) * | 1999-01-29 | 2001-03-19 | Pfizer Prod Inc | Azithromycin combination for emesis control in dogs |
JP2001139477A (ja) * | 1999-11-17 | 2001-05-22 | Coherent Technology:Kk | 創傷部位の組織細胞増殖促進液 |
AU772029B2 (en) * | 2000-03-08 | 2004-04-08 | Sumika Enviro-Science Co., Ltd. | Method for denaturing allergens |
FR2809006B1 (fr) * | 2000-05-18 | 2002-08-02 | Oreal | Utilisation du manganese dans des compositions destinees a combattre la paleur de la peau |
FR2809005B1 (fr) * | 2000-05-18 | 2002-12-27 | Oreal | Utilisation du manganese dans le traitement des rides |
AU8298801A (en) | 2000-07-26 | 2002-02-05 | John K Vyden | Methods for treating atopic disorders |
JP5140218B2 (ja) | 2001-09-14 | 2013-02-06 | 有限会社コヒーレントテクノロジー | 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法 |
US20030059450A1 (en) | 2001-09-24 | 2003-03-27 | Maibach Howard I. | Method and topical formulation for treating skin conditions associated with aging |
JP3988827B2 (ja) * | 2001-12-05 | 2007-10-10 | オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド | 負および正の酸化還元電位(orp)水を生成するための方法および装置 |
US7081247B2 (en) * | 2002-05-20 | 2006-07-25 | Nidaria Technology Ltd. | Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting |
US8404751B2 (en) * | 2002-09-27 | 2013-03-26 | Hallux, Inc. | Subunguicide, and method for treating onychomycosis |
US20050118278A1 (en) * | 2002-12-09 | 2005-06-02 | Ananiev Evgeny N. | Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects |
US6902723B2 (en) * | 2003-08-14 | 2005-06-07 | The Gillette Company | Enhanced efficacy antiperspirant compositions containing strontium |
US6923952B2 (en) * | 2003-08-14 | 2005-08-02 | The Gillette Company | Enhanced efficacy antiperspirant compositions containing strontium or calcium |
US20050196462A1 (en) * | 2003-12-30 | 2005-09-08 | Oculus Innovative Sciences, Inc. | Topical formulation containing oxidative reductive potential water solution and method for using same |
US9168318B2 (en) | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
US20050139808A1 (en) * | 2003-12-30 | 2005-06-30 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and process for producing same |
KR101249639B1 (ko) * | 2003-12-30 | 2013-04-01 | 오클루스 이노바티브 사이언시즈 인코포레이티드 | 산화환원전위 수용액, 그의 제조방법 및 이를 사용하는방법 |
WO2006076119A2 (en) * | 2005-01-12 | 2006-07-20 | Immuneregen Biosciences, Inc. | Treatment of skin diseases |
AU2006226750B2 (en) * | 2005-03-23 | 2012-07-19 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
MX2007013774A (es) | 2005-05-02 | 2008-01-29 | Oculus Innovative Sciences Inc | Metodo para utilizar solucion de agua con potencial oxido reductor en aplicaciones dentales. |
CA2637178C (en) * | 2006-01-20 | 2018-09-04 | Oculus Innovative Sciences, Inc. | Methods of preventing or treating sinusitis with oxidative reductive potential water solution |
WO2008023960A1 (en) * | 2006-08-25 | 2008-02-28 | Taewung Els, Inc. | Uses of rare earth elements for hair improvement |
KR100818175B1 (ko) | 2007-12-12 | 2008-04-02 | 주식회사 태웅이엘에스 | 모발처리용 조성물 |
JP2010200971A (ja) * | 2009-03-03 | 2010-09-16 | Hoyu Co Ltd | 異常脱毛予測/推定方法、異常脱毛予防/防止方法及び異常脱毛防止剤評価方法 |
CN102480972B (zh) | 2009-06-15 | 2014-12-10 | 奥古露丝创新科学公司 | 含有次氯酸的溶液及其使用方法 |
DE102012110009A1 (de) * | 2012-10-19 | 2014-04-24 | Thomas Gniech | Mittel zur Linderung oder gegen Migräneschmerzen |
EP2938317A1 (de) * | 2012-12-27 | 2015-11-04 | Jean-Claude Epiphani | Verfahren zur herstellung einer öl-in-wasser-emulsion aus einem öliger wirkstoff für kosmetische, nahrungsmittel- oder pharmazeutische verwendung |
JP2016514024A (ja) | 2013-03-14 | 2016-05-19 | ハラックス,インコーポレイテッド | 爪部の感染症、疾患または障害の治療方法 |
FR3031677B1 (fr) * | 2015-01-16 | 2019-06-07 | L'oreal | Composition cosmetique pour administration par voie topique pour renforcer la barriere cutanee. |
CN110573451B (zh) * | 2017-05-19 | 2021-08-06 | 三得利控股株式会社 | 分配头以及利用该分配头的饮料喷出通路的清洗方法 |
EP3873393A4 (de) | 2018-10-31 | 2022-08-03 | Yeditepe Universitesi | Verwendung von nanoskaligen lanthanidborat (dysprosiumborat und erbiumborat)-verbindungen zur wundheilung und verfahren zu ihrer herstellung |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE297062C (de) * | ||||
GB997975A (en) * | 1964-01-31 | 1965-07-14 | Aristotelis Papageorgiou Lambo | Pharmaceutical compositions containing a cresol or a mixture of cresols |
GB1072355A (en) * | 1964-06-17 | 1967-06-14 | Michael Collin | Antiseptic and anti-pruretic solution containing camphor |
US3519711A (en) * | 1967-09-01 | 1970-07-07 | Robert E Svigals | Composition and method of treating pruritic conditions of the skin |
IE35991B1 (en) * | 1971-01-22 | 1976-07-21 | Comprehensive Pharmaceuticals | Improvements in or relating to the treatment of diseases of the skin and mucosa |
LU65373A1 (de) * | 1972-05-17 | 1973-11-23 | ||
US3888976A (en) * | 1972-09-21 | 1975-06-10 | William P Mlkvy | Zinc and strontium ion containing effervescent mouthwash tablet |
US3772431A (en) * | 1972-09-21 | 1973-11-13 | W Mlkvy | Effervescent mouthwash tablet |
DE2715711A1 (de) * | 1977-04-07 | 1978-10-19 | Robugen Gmbh | Topisch anwendbares arzneimittel zur behandlung von viruserkrankungen der haut und der schleimhaut |
DE3030215A1 (de) * | 1980-08-09 | 1982-03-18 | Bergwerksverband Gmbh, 4300 Essen | Wirbelbett-feuerung |
US4477439A (en) * | 1981-04-13 | 1984-10-16 | Walter J. Monacelli | Treatment of irritated and excoriated areas around the stoma of ostomy patients |
EP0090798A1 (de) * | 1981-10-09 | 1983-10-12 | Ferring AB | Arzneimittel auf der basis eines antagonisten der p-substanz |
AU556817B2 (en) * | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
GB8320203D0 (en) * | 1983-07-27 | 1983-09-01 | Horrobin D F | Anti-viral compositions |
DE3338957A1 (de) * | 1983-10-27 | 1985-05-15 | Keyhan Dipl.-Ing. 6908 Wiesloch Ghawami | Enthaarungsmittel |
DE3443985A1 (de) * | 1984-12-01 | 1986-06-05 | Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen | Arzneimittelzubereitungen gegen mykotische und bakterielle infektionen mit einem gehalt an wirkstoffen, welche zink in ionisierter form freisetzen |
IT1214611B (it) * | 1985-05-22 | 1990-01-18 | Schiena Ricerche | Composti per uso cosmetico dermatologico e relative composizioni. |
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
DE3584837D1 (de) * | 1985-10-08 | 1992-01-16 | Psori Med Ag | Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten. |
US4735802A (en) * | 1986-05-05 | 1988-04-05 | Le Bich N | Topical dermatological composition and method of treatment |
FR2599967B1 (fr) * | 1986-06-16 | 1989-03-31 | Bfb Etudes Rech Experimentale | Utilisation de sel de zinc et de la vitamine b6 pour enrayer les processus alopeciques et/ou seborrheiques. |
US4986981A (en) * | 1986-07-07 | 1991-01-22 | Den Mat Corporation | Toothpaste having low abrasion |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
SE8701372L (sv) * | 1987-04-02 | 1988-10-03 | Boliden Ab | Foerfarande och medel foer konservering av hoe |
AU616502B2 (en) * | 1988-04-22 | 1991-10-31 | Medvet Science Pty. Ltd. | Treatment of inflammatory disorders in humans |
DE3929411A1 (de) * | 1988-09-22 | 1990-03-29 | Siegfried Natterer | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung |
US4938969A (en) * | 1988-11-14 | 1990-07-03 | Milor Scientific, Ltd. | Method for the treatment of aging or photo-damaged skin |
CA2014201A1 (en) * | 1989-04-26 | 1990-10-26 | Albemarle Corporation | Solid non-hygroscopic trialkylamine oxides |
GB8916625D0 (en) * | 1989-07-20 | 1989-09-06 | Bryce Smith Derek | Respiratory tract spray preparations |
SU1679008A1 (ru) * | 1989-07-26 | 1991-09-23 | Производственно Промышленное Объединение "Железобетон" | Арматурный элемент дл дисперсного армировани бетона |
US5202130A (en) * | 1989-08-31 | 1993-04-13 | The Johns Hopkins University | Suppression of eczematous dermatitis by calcium transport inhibition |
US5296476A (en) * | 1989-09-08 | 1994-03-22 | Henderson Esther G | Skin care compositions |
ATE94399T1 (de) * | 1990-01-29 | 1993-10-15 | Wogepharm Gmbh | Verfahren zur herstellung von mitteln zur therapie von hauterkrankungen. |
EP0451300B1 (de) * | 1990-04-10 | 1994-10-26 | Romuald Dr. Kowalski | Bariumsulfat-kolloidale Dispersion enthaltende Zusammensetzung |
US5401730A (en) * | 1990-07-06 | 1995-03-28 | The Hope Heart Institute | Method for reducing platelet aggregation |
WO1993001160A1 (en) * | 1991-07-05 | 1993-01-21 | Merck Sharp & Dohme Limited | Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
US5610183A (en) * | 1991-07-10 | 1997-03-11 | Merck, Sharp & Dohme Ltd. | Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy |
RU2038072C1 (ru) * | 1991-11-01 | 1995-06-27 | Государственный российский научно-исследовательский институт органической химии и технологии | Крем для защиты кожи от химических веществ и способ его получения |
GB9201179D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
AU4777293A (en) * | 1992-07-20 | 1994-02-14 | Arch Development Corporation | Control of wound scar production with calcium antagonists alone or in a combination with a steroid |
DE9211006U1 (de) * | 1992-08-17 | 1993-12-16 | Kao Corp Gmbh | Mittel zur Haarbehandlung |
GB9222486D0 (en) * | 1992-10-26 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
AU5589594A (en) * | 1992-10-29 | 1994-05-24 | C-P Technology Limited Partnership | Mixtures or complexes containing calcium and sulfate |
EP0799018A4 (de) * | 1994-12-21 | 2000-03-29 | Cosmederm Technologies | Formulierungen und verfahren zur verminderung von hautirritationen |
US5716625A (en) * | 1994-12-21 | 1998-02-10 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
ATE237298T1 (de) * | 1994-12-21 | 2003-05-15 | Cosmederm Technologies | Formulierungen und verfahren zur verminderung von hautirritationen |
-
1995
- 1995-10-26 FR FR9512658A patent/FR2740335B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-14 DE DE69635010T patent/DE69635010T2/de not_active Expired - Lifetime
- 1996-10-14 AT AT96402182T patent/ATE300948T1/de not_active IP Right Cessation
- 1996-10-14 ES ES96402182T patent/ES2246493T3/es not_active Expired - Lifetime
- 1996-10-14 EP EP96402182A patent/EP0770392B1/de not_active Expired - Lifetime
- 1996-10-24 NO NO964517A patent/NO964517L/no unknown
- 1996-10-25 CA CA002188892A patent/CA2188892C/fr not_active Expired - Fee Related
- 1996-10-25 JP JP08284318A patent/JP3112844B2/ja not_active Expired - Fee Related
- 1996-10-28 US US08/738,811 patent/US5900257A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE300948T1 (de) | 2005-08-15 |
FR2740335A1 (fr) | 1997-04-30 |
CA2188892A1 (fr) | 1998-04-25 |
CA2188892C (fr) | 2008-06-17 |
DE69635010T2 (de) | 2006-04-20 |
JPH09165341A (ja) | 1997-06-24 |
FR2740335B1 (fr) | 1997-12-19 |
JP3112844B2 (ja) | 2000-11-27 |
NO964517D0 (no) | 1996-10-24 |
ES2246493T3 (es) | 2006-02-16 |
US5900257A (en) | 1999-05-04 |
EP0770392B1 (de) | 2005-08-03 |
EP0770392A2 (de) | 1997-05-02 |
EP0770392A3 (de) | 1997-05-07 |
NO964517L (no) | 1997-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69635010D1 (de) | Verwendung von Mangan-, Yttrium- oder einigen Lanthanidsalzen in einer kosmetischen, dermatologischen oder pharmazeutischen Zusammensetzung insbesondere zur Behandlung empflindlicher Haut | |
DE69611343T2 (de) | Verwendung von Lanthanide-, Zinn-, Mangan-, Yttrium-, Kobalt-, Barium-, Strontiumsalzen in einem Hautpflegemittel | |
DE69716251T2 (de) | Verwendung von oktoxyglyzerin in einer kosmetischen und/oder dermatologischen zusammensetzung als wirkstoff zur behandlung von seborrhoe und/oder akne | |
DE69024039T3 (de) | VERWENDUNG VON HYALURONSÄURE IN KOMBINATION MIT ASCORBINSÄURE, ANTITUMORMITTELN UND/ODER NSAIDs ZUR BEHANDLUNG VON KREBS | |
DE69221856T2 (de) | Oxyacanthin enthaltende kosmetische oder pharmazeutische insbesondere dermatologische zusammensetzung zur stimulierung des haarwachstums oder verzoegerung des haarausfalls | |
EP0487648A4 (en) | Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing | |
ATE177640T1 (de) | Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung | |
DE69435330D1 (de) | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen | |
ATE186834T1 (de) | Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut | |
DE602004003587D1 (de) | Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite | |
ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
DE69819514D1 (de) | Verwendung von physiologisch verträglichen vanadiumverbindungen, salzen und komplexen | |
DE69305433D1 (de) | Kosmetische oder dermatologische Zusammensetzung zur Hautdepigmentierung enthaltend eine di- oder tri-Kaffeoylchinasäure oder eine Mischung davon | |
DE59708780D1 (de) | Verfahren und mittel zur dauerhaften verformung von keratinfasern | |
DE1155677T1 (de) | Methoden und Zusammensetzungen zur Inhibierung der Radikal initierten Polymerisation in der Haut und dem Haar | |
DE69900160D1 (de) | Harnstoff enthaltende Zusammensetzung und ihre kosmetische und dermatologische Verwendung | |
BR9807157A (pt) | Composto, composição, utilização de um composto e processo de tratamento cosmético dos sinais do envelhecimento cutâneo | |
RU96115137A (ru) | Применение диметикона для лечения афт и стоматита | |
DE3886247T2 (de) | Verwendung eines Haarkosmetischen Mittels zur vorbeugung von gesplissenem Haar oder gebrochenem Haar und zur Behandlung von beschädigtem Haar. | |
DE69922471D1 (de) | Topische Borneol und Wismutgallat enthaltende pharmazeutische Zubereitungen zur Wundheilung | |
DE69427949T2 (de) | Acriflavine enthaltende Arzneimittel verwendbar zur Behandlung von Herpes und Zona | |
DE59203472D1 (de) | Verwendung von dl-valin, dessen estern und/oder salzen zur bekämpfung von kopfschuppen. | |
AU5729194A (en) | Compositions for treating corns, calluses and warts comprising salicylic acid and lanthanide | |
ATE167053T1 (de) | Zusammensetzung zur bekämpfung von hautflecken und/oder hautalterung und ihre verwendungen | |
DE69311286T2 (de) | Verwendung von Melatonin zur Herstellung eines Arzneimittels zur Behandlung von Scleroderma und der Sarcoidosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |